Meitav Investment House’s Labcorp LH Stock Holding History

Meitav Investment House’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,586	Closed	-$776K	–	439
2018 Q1	$776K	Sell	5,586 -2,762	-33%	-$406K	0.04%	224
2017 Q4	$1.15M	Buy	+8,348	New	+$1.1M	0.07%	124

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Meitav Investment House's LH Position: Q2 2018 in Review

Meitav Investment House sold out of Labcorp (LH) in Q2 2018, closing a stake of 5,586 shares — an estimated $776K sold.

Meitav Investment House first reported a position in LH in Q4 2017 and held it in 2 quarters. The position peaked at $1.15M in Q4 2017. 786 funds tracked by Wall St. Rank hold LH as of Q2 2018.

Meitav Investment House reported no remaining Labcorp position as of Q2 2018 after selling out during the quarter.
Meitav Investment House sold 5,586 Labcorp shares in Q2 2018, an estimated $776K.
Meitav Investment House first reported a position in Labcorp in Q4 2017 and held it in 2 quarters.
Meitav Investment House's Labcorp position peaked at $1.15M in Q4 2017.
786 funds tracked by Wall St. Rank held Labcorp as of Q2 2018.

Based on Meitav Investment House's 13F filing for Q2 2018, filed 14 Aug 2018.